EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Raised intracranial pressure alters cortical vascular function and cephalic allodynia

Olivia Grech iD, Eloisa Rubio-Beltran iD, Emily C Stanyer, Alejandro Labastida-Ramirez, Gareth G Lavery, Lisa J Hill iD, Philip R Holland iD, Alexandra J Sinclair iD

Brain · 2025

DOI: 10.1093/brain/awae415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2025. Verfasst von Olivia Grech und 7 weiteren Autor:innen. Beteiligte Einrichtung: Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham B15 2TT, UK. Hauptthemen laut MEDLINE: Hyperalgesia, Cerebrovascular Circulation, Intracranial Hypertension, Intracranial Pressure. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bristol Myers Squibb, Brain Research UK, Allergan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Raised intracranial pressure (ICP) is associated with altered cerebral haemodynamics and cephalic pain. The relationship between the algetic response and cortical neurovascular changes in raised ICP is unclear. This study aimed to evaluate this relationship and determine whether lowering ICP (using a glucagon-like peptide-1 receptor agonist) could ameliorate the algetic response. We also sought to explore the role of calcitonin gene-related peptide in cephalic pain driven by raised ICP by inhibiting calcitonin gene-related peptide signalling and quantifying changes in the algetic response. In a rat model of raised ICP, created by intracisternal kaolin injection, mechanical thresholds were measured alongside steady-state potential and cerebral blood flow responses to spreading depolarization. Nuclear magnetic resonance spectroscopy evaluated energetic substrates in animals with raised ICP ex vivo. The glucagon-like peptide-1 receptor (GLP-1R) agonist exenatide and the calcitonin gene-related peptide receptor (CGRP-R) antagonist olcegepant were injected daily, and measurements were repeated. Kaolin increased ICP [median (range) 15.96 (8.97) mmHg, n = 8] versus controls [6.02 (1.79) mmHg, n = 6, P = 0.0007]. Animals with raised ICP exhibited reduced mechanical thresholds [mean (standard deviation) hind paw baseline: 5.78 (2.81) g, Day 7: 3.34 (2.22) g, P < 0.001; periorbital baseline: 6.13 (2.07) g, Day 7: 2.35 (1.91) g, n = 12, P < 0.001]. Depolarization and repolarization durations were increased [depolarization, raised ICP: 108.81 (222.12) s, n = 11, controls: 37.54 (108.38) s, n = 9, P = 0.038; repolarization, raised ICP: 1824.26 (3499.54) s, n = 12, controls: 86.96 (140.05) s, n = 9, P < 0.0001]. Cerebral blood flow change was also reduced [85.55 (30.84)%, n = 9] compared with controls [217.64 (37.70)%, n = 8, P < 0.0001]. Substrates for cellular energetics (ADP, ATP and NAD+) were depleted in rodent brains with raised ICP (P = 0.009, P = 0.018 and P = 0.011, respectively). Exenatide significantly lowered ICP [exenatide: 9.74 (6.09) mmHg, n = 19, vehicle: 18.27 (6.67) mmHg, n = 16, P = 0.004] and rescued changes in mechanical withdrawal. Exenatide recovered characteristic spreading depolarization responses [depolarization duration, exenatide: 56.46 (25.10) s, n = 7, vehicle: 115.98 (58.80) s, n = 6, P = 0.033; repolarization duration, exenatide: 177.55 (562.88) s, n = 7, vehicle: 800.85 (1988.67) s, n = 6, P = 0.002]. In the setting of raised ICP, olcegepant prevented changes in periorbital mechanical thresholds. We conclude that raised ICP disrupted the cortical neurovascular responses, reduced algetic thresholds and depleted crucial energetic substrates. Exenatide reduced ICP, improving algetic thresholds and cortical neurovascular changes. Importantly, olcegepant alleviated the cerebral algesia, suggesting a role for calcitonin gene-related peptide in driving pain responses in elevated ICP. These studies support the rationale that reducing ICP improves cephalic pain in conditions of raised ICP. Furthermore, the data suggest that headache pain in diseases associated with raised ICP could be ameliorated therapeutically though blockade of the calcitonin gene-related peptide pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperalgesiaCerebrovascular CirculationIntracranial HypertensionIntracranial PressureCerebral CortexAnimalsRatsMaleRats, Sprague-DawleyCalcitonin Gene-Related PeptideDisease Models, AnimalExenatideKaolin

Stichwörter der Autor:innen

calcitonin gene-related peptide receptor antagonistexenatideglucagon-like peptide receptor agonistolcegepant

Substanzen

Calcitonin Gene-Related PeptideExenatideKaolin

Autor:innen und Institutionen

  • Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham B15 2TT, UK.
  • Biomedical Sciences, College of Medicine and Health, University of Birmingham, Birmingham B15 2TT, UK.
  • Headache Group, Wolfson Sensory, Pain and Regeneration Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE1 3RB, UK.
  • Sleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK.
  • Centre for Systems Health and Integrated Metabolic Research, Department of Biosciences, School of Science and Technology, Nottingham Trent University, Clifton Campus, Nottingham NG11 8NS, UK.

ORCID-Profile: Olivia Grech, Eloisa Rubio-Beltran, Lisa J Hill, Philip R Holland, Alexandra J Sinclair

Förderung

  • Bristol Myers Squibb
  • Brain Research UK
  • Allergan
  • Eli Lilly
  • Kallyope
  • Almirall
  • NIHR
  • Biomedical Science

Zitieren

APA

Grech, O., Rubio-Beltran, E., Stanyer, E. C., Labastida-Ramirez, A., Lavery, G. G., Hill, L. J., Holland, P. R., & Sinclair, A. J. (2025). Raised intracranial pressure alters cortical vascular function and cephalic allodynia. Brain. https://doi.org/10.1093/brain/awae415

Vancouver

Grech O, Rubio-Beltran E, Stanyer EC, Labastida-Ramirez A, Lavery GG, Hill LJ, et al. Raised intracranial pressure alters cortical vascular function and cephalic allodynia. Brain. 2025. doi:10.1093/brain/awae415

BibTeX
@article{Grech2025,
  author = {Grech, Olivia and Rubio-Beltran, Eloisa and Stanyer, Emily C and Labastida-Ramirez, Alejandro and Lavery, Gareth G and Hill, Lisa J and Holland, Philip R and Sinclair, Alexandra J},
  title = {Raised intracranial pressure alters cortical vascular function and cephalic allodynia},
  journal = {Brain},
  year = {2025},
  doi = {10.1093/brain/awae415}
}
Kostenlos starten →